Celldex Therapeutics Inc (CLDX)
3.79
-0.17 -4.29%
NASDAQ
Apr 18, 20:00
Delayed 2m
USD
View All Key Stats
CLDX Key Stats
| Income Statement | |
| Revenue (TTM) | 9.536M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -15.66 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -151.18M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -533.0% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 47.15M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.146 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 0.38 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -15.59M |
| Return on Equity (TTM) | Upgrade |
View All CLDX News
CLDX News
-
WireHeadlineTime (ET)
-
SA Breaking News04/08 12:56
-
Yahoo04/06 09:30
-
SA Breaking News04/02 09:17
-
Globe Newswire04/02 08:00
-
MT Newswires04/01 13:53
-
Globe Newswire04/01 13:00
-
Yahoo03/20 09:30
-
Yahoo03/13 13:19
-
Yahoo03/08 11:04
-
Yahoo03/08 07:45
View All Events
CLDX Events
| Date | Type | Description |
|---|---|---|
| 08/08/2019 16:30 EDT | Misc | Celldex Therapeutics Inc Second Quarter Earnings Conference Call in 2019 |
| 05/10/2019 | Earnings | Celldex Therapeutics Inc First Quarter Earnings Results in 2019 |
| 03/07/2019 16:30 EST | Misc | Celldex Therapeutics Inc Fourth Quarter Earnings Conference Call in 2018 |
| 03/07/2019 | Earnings | Celldex Therapeutics Inc Fourth Quarter Earnings in 2018 Release |
| 03/07/2019 | Misc | Celldex Therapeutics Inc Annual Report in 2018 |
| 02/11/2019 | Splits | Ratio: 666667:10000000 |
| 11/07/2018 | Earnings | Celldex Therapeutics Inc Third Quarter Earnings Results in 2018 |
| 08/08/2018 16:30 EDT | Misc | Celldex Therapeutics Inc Second Quarter Earnings Conference Call in 2018 |
| 08/08/2018 | Earnings | Celldex Therapeutics Inc Second Quarter Earnings Results in 2018 |
| 06/01/2018 | Misc | Celldex Therapeutics Inc Annual General Meeting in 2017 |
CLDX Fundamentals
Income Statement View Statement
CLDX Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
CLDX One Page Reports
- One Page Report Download
CLDX Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 3.79 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.celldex.com
- Investor Relations URL: http://ir.celldex.com/index.cfm
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: May. 10, 2019
- Last Earnings Release: Mar. 07, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379.
CLDX Excel Add-In Codes
- Name: =YCI("CLDX","name")
- Description: =YCI("CLDX","description")
- Sector: =YCI("CLDX","sector")
- Industry: =YCI("CLDX","industry")
- Est. Current Fiscal Year End: =YCI("CLDX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other CLDX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CLDX Tweets Stocktwits
Advertisement
